Happy to share our new @biorxivpreprint on the effects of anti-α4β7 therapy on GALT in ulcerative colitis! #mehandrulab #mountsinai Targeting intestinal lymphoid structures represents a new paradigm in IBD care! https://www.biorxiv.org/content/10.1101/2023.01.19.524731v1.full.pdf+html